Recurrence of Prosthetic Aortic Valve Endocarditis After Percutaneous Mechanical Aspiration Authors: Sampada Kuwar, Raja Saravanan, Kubiat Udoh, Sriveni Tangellapelli, Koteswara Pothineni Published: 2026 ABSTRACT BackgroundProsthetic valve endocarditis is a dreaded complication after transcatheter aortic valve replacement, especially in older patients with multiple comorbidities, who are poor surgical candidates. We describe a case of prosthetic aortic valve endocarditis in a patient who underwent percutaneous mechanical aspiration (PMA) and its sequelae over the following year.Case SummaryThe patient presented with fever and chills after flu and respiratory syncytial virus vaccines and was found to have positive blood cultures for methicillin-resistant Staphylococcus aureus and bioprosthetic aortic valve endocarditis. He was a poor surgical candidate and underwent PMA with an AngioVac device with the development of a perivalvular abscess and pericardial effusion on subsequent admissions.DiscussionPMA is increasingly being used for the treatment of endocarditis, especially right sided, but there is limited evidence on its use in left-sided endocarditis due to high risk of complications.Take-Home MessageThere is a high risk of complications with PMA in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates. History of Presentation An 85-year-old man presented with diffuse urticarial rash, 1 day after flu and respiratory syncytial virus vaccines, which did not improve with diphenhydramine. He reported 1 episode of subjective fever and chills for 2–3 hours the previous day and had a low-grade fever of 100.8 °F on presentation.Take-Home Message•There is a high risk of complications with percutaneous mechanical aspiration in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates. Take-Home Message •There is a high risk of complications with percutaneous mechanical aspiration in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates. •There is a high risk of complications with percutaneous mechanical aspiration in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates. There is a high risk of complications with percutaneous mechanical aspiration in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates. Past Medical History The patient had a history of chronic lymphocytic leukemia in remission, persistent atrial fibrillation, diastolic congestive heart failure, hypothyroidism, essential hypertension, prostate cancer in remission, aortic stenosis with transcatheter aortic valve replacement (TAVR) 2.5 years before presentation, recurrent bacteremia with methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus agalactiae, and Enterococcus faecalis after TAVR, and seizure disorder. The current medications include apixaban, furosemide, levetiracetam, levothyroxine, metoprolol succinate, nitroglycerin, pantoprazole, sertraline, spironolactone, and multivitamins. Differential Diagnosis The differential diagnosis included blood stream infection, infective endocarditis (IE), allergic reaction to vaccines, community-acquired pneumonia, serum sickness, and drug eruption. Investigations Blood cultures were positive for MRSA. Transesophageal echocardiography (TEE) showed a large vegetation measuring 0.715 × 0.6 × 2.4 cm on the ventricular side of the valve and a thin, hypermobile vegetation on the aortic side of the valve that measured 1.64 cm in diameter. The bioprosthetic valve was well seated without evidence of intra- or paravalvular regurgitation with preserved left and right systolic ventricular function with trace regurgitation of the mitral and tricuspid valves (Figure 1, Videos 1 and 2). Transthoracic echocardiography (TTE) 2 months previously showed an aortic valve mean pressure gradient of 8 mm Hg with preserved systolic function.Figure 1Transesophageal Echocardiography Demonstrating Transverse Dimensions of the Bioprosthetic Aortic Valve VegetationTransesophageal echocardiography showing a vegetation on the bioprosthetic aortic valve with transverse measurements of approximately 0.715 × 0.6 cm. Transesophageal Echocardiography Demonstrating Transverse Dimensions of the Bioprosthetic Aortic Valve Vegetation Transesophageal echocardiography showing a vegetation on the bioprosthetic aortic valve with transverse measurements of approximately 0.715 × 0.6 cm. Management Because of risk factors including advanced age and multiple comorbidities, the patient was deemed to be a poor candidate for surgical intervention. The Society of Thoracic Surgeons risk assessment revealed a Predicted Risk of Mortality score of 31.9% and a morbidity and mortality risk of 50.6%, indicating extremely high operative risk. Considering history of recurrent bacteremia, multiple hospital stays, and a new large vegetation of the bioprosthetic aortic valve, percutaneous mechanical aspiration (PMA) with a cerebral protective device was considered an appropriate option for source control of the infection and prevent further morbidity. A decision was made to proceed with PMA for the aortic valve vegetations with a large bore aspiration device, AngioVac (AngioDynamics). Intraoperative TEE showed 3 large mobile vegetations on the aortic valve prosthesis. Vascular access was obtained via the left femoral artery and right common femoral vein. Right radial artery access was also obtained; an arteriogram showed a small but patent vessel. Despite multiple attempts with multiple guidewires, the subclavian artery could not be accessed because of a localized dissection at the elbow, and use of a sentinel device was abandoned because of technical difficulty. A 22-F dry seal sheath was placed in the aorta, and a 17-F venous return cannula was placed in the right common femoral vein. The circuit was de-aired and connected to the extracorporeal membrane oxygenation pump. The AngioVac device was placed through the dry seal sheath on the left femoral artery, 4 cm above the aortic valve prosthesis. The inner cannula was manipulated under fluoroscopy and TEE guidance to reach a point just above the vegetation. The pump was turned on, and the Angiovac device was used to debride the aortic valve prosthesis with removal of 90% of visible vegetation. The extracorporeal membrane oxygenation pump was then separated, and the sheath in the right femoral vein was removed with adequate hemostasis. The patient had complications of significant hemorrhage from the left femoral artery, which was managed with repair with a patch angioplasty 1 day after the procedure. Outcome and Follow-Up The patient was unable to be extubated after the procedure because of global neuromuscular weakness resulting in low tidal volumes. He was successfully extubated on postoperative day 4. TTE 3 days after the procedure showed no regurgitation at the aortic valve, with the bioprosthetic valve well positioned, with an aortic valve pressure gradient of 2 mm Hg. The patient demonstrated delirium in the intensive care unit, but did not have any evidence of focal deficits or persisting mental status change. Computed tomography of the head 7 days after the procedure did not demonstrate any intracranial hemorrhage or infarct. Because of pneumonitis from daptomycin, antibiotics were transitioned to vancomycin and ceftaroline and discharged after 14 days with antibiotics. Neurological status was at baseline for the patient at discharge. Repeat blood cultures after PMA showed no growth. He presented again in 5 months with severe hypotension with positive cultures for MRSA. TTE showed a large vegetation ∼1.7 cm on the TAVR prosthesis with an abscess in the posterior annulus (Figure 2, Video 3, Video 4, Video 5, Video 6). The patient was deemed a poor candidate for any intervention and was conservatively managed with antibiotics.Figure 2Transesophageal Echocardiography Demonstrating Perivalvular Abscess in the Posterior Annulus of the Bioprosthetic Aortic ValveTransthoracic echocardiography showing an abscess cavity located in the posterior annulus adjacent to the bioprosthetic aortic valve. Transesophageal Echocardiography Demonstrating Perivalvular Abscess in the Posterior Annulus of the Bioprosthetic Aortic Valve Transthoracic echocardiography showing an abscess cavity located in the posterior annulus adjacent to the bioprosthetic aortic valve. Ten days later, he presented with new chest pressure and was found to have a large pericardial effusion with no signs of tamponade and moderate left pleural effusion (Figure 3, Videos 7 and 8). The patient was treated conservatively. Two days later, the patient transitioned to hospice and died on the same day.Figure 3Transthoracic Echocardiography Demonstrating a Large Pericardial EffusionTransthoracic echocardiography in the parasternal long-axis view demonstrating a large circumferential pericardial effusion. The effusion appears as an echo-free space surrounding the heart. Transthoracic Echocardiography Demonstrating a Large Pericardial Effusion Transthoracic echocardiography in the parasternal long-axis view demonstrating a large circumferential pericardial effusion. The effusion appears as an echo-free space surrounding the heart. Discussion Bioprosthetic aortic valve IE is a life-threatening condition with high mortality and poor clinical outcomes with an incidence of 0.3–2.0 per 100 person-years.1 The demographic characteristics of IE has evolved in the past few decades, with increasing populations belonging to the following groups: intravenous drug users and elderly patients with prosthetic devices. Along with the high risk of endocarditis itself, they are poor surgical candidates, in which cases, PMA has emerged as a potential salvage strategy aimed at reducing infectious burden.2 The decision to pursue PMA in this case was made after multidisciplinary evaluation involving cardiology, cardiothoracic surgery, and infectious disease specialists as a salvage option to achieve temporary source control while balancing procedural risk against the potential consequences of untreated infection. PMA for vegetations is increasingly being used for IE, especially for right-sided endocarditis, because of the ease of access and low risk of complications. Left-sided PMA has additional risks of embolization into systemic circulation, increasing the risk of cerebrovascular accident and involves more invasive maneuvers such as a transseptal route of access. Despite these risks, the procedure was performed as a salvage therapy to achieve source control in the setting of high operative risk and clinical deterioration. Our case highlights several unique aspects of PMA use in left-sided prosthetic valve endocarditis. In our patient, a large bore device (AngioVac) was used because of the large size of the vegetation and to reduce the risk of embolization during the procedure as the vegetation was left-sided. After the procedure, our patient demonstrated clearance of bacteremia, suggesting effective initial debulking of the vegetation. However, the subsequent clinical course highlights important limitations of this approach. Our patient unfortunately had a recurrence of vegetation, bacteremia, and complications of perivalvular abscess and pericardial effusion. Although perivalvular abscess and pericardial effusion are known complications of prosthetic valve IE itself, the temporal association raises concern that incomplete vegetation removal or procedural manipulation may contribute to adverse remodeling or persistent infection.3 This could in a major part be due to the technically difficult nature of the procedure or size of vegetation, preventing complete removal of the vegetation. Cerebral protection device is routinely used in procedures involving the left side of the heart to decrease the risk of cerebral embolization. Notably, cerebral protection device was not used during the procedure because of technical difficulty, making our patient vulnerable to possible embolization. The patient was closely monitored in the intensive care unit and did not demonstrate any symptoms of stroke with a negative result of the computed tomography of the head after the procedure. Current evidence supporting PMA in IE is largely derived from observational studies and registries focused on right-sided disease.4,5 There is a significant lack of data on PMA in left-sided endocarditis, especially aortic valve endocarditis, likely attributable to the high risk of complications in these cases. Data on left-sided PMA, particularly involving the aortic valve, are limited to isolated case reports and small series with heterogeneous outcomes.6,7 Although risks of procedural complications are high in these cases, there is a possibility that certain subsets of them can benefit from PMA, such as smaller vegetations, as opposed to larger vegetations, which have shown higher complications with interventional measures.8 Larger studies are needed to assess these nuances in the selection of patients. Conclusions This case illustrates the use of PMA as a salvage strategy for large bioprosthetic aortic valve vegetations in a patient with recurrent IE with prohibitive risk for surgical intervention. PMA resulted in short-term microbiologic clearance and preservation of prosthetic valve function but was followed by recurrent infection and structural complications. Although theoretically PMA could help with debulking and decreasing microbial burden, there are no sufficient data to guide its use in endocarditis, especially left-sided valves, which are technically challenging. Outcomes after PMA should therefore be interpreted cautiously, and the procedure should be reserved for carefully selected patients after multidisciplinary evaluation. There is a lack of prospective data to define appropriate patient selection, procedural techniques, embolic protection strategies, and long-term outcomes compared with medical therapy alone. Larger studies and registries focused on left-sided disease are needed to clarify whether PMA can meaningfully improve outcomes in specific high-risk populations. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.